Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | NFAT5 |
| Upstream (Parents) |
|---|
| (<<) COIL → NFAT5 |
| (<<) HPCAL1 → NFAT5 |
| (<<) PPP2R5C → NFAT5 |
| (<<) SLC20A1 → NFAT5 |
| (<<) WASF2 → NFAT5 |
| Downstream (Children) |
|---|
| NFAT5 → ACTN3 (>>) |
| NFAT5 → APH1B (>>) |
| NFAT5 → ARAF (>>) |
| NFAT5 → ARSA (>>) |
| NFAT5 → BMPR2 (>>) |
| NFAT5 → CACNA1I (>>) |
| NFAT5 → CASKIN1 (>>) |
| NFAT5 → CBL (>>) |
| NFAT5 → CDC42EP5 (>>) |
| NFAT5 → CDK6 (>>) |
| NFAT5 → CISH (>>) |
| NFAT5 → DLGAP3 (>>) |
| NFAT5 → DYNC1LI2 (>>) |
| NFAT5 → EFNB2 (>>) |
| NFAT5 → EGFR (>>) |
| NFAT5 → EIF2C2 (>>) |
| NFAT5 → EML4 (>>) |
| NFAT5 → ENC1 (>>) |
| NFAT5 → EWSR1 (>>) |
| NFAT5 → FBXO32 (>>) |
| NFAT5 → FLJ35934 (>>) |
| NFAT5 → GNB4 (>>) |
| NFAT5 → GSTZ1 (>>) |
| NFAT5 → GYS1 (>>) |
| NFAT5 → HES7 (>>) |
| NFAT5 → HS3ST2 (>>) |
| NFAT5 → HSPA4 (>>) |
| NFAT5 → KCTD12 (>>) |
| NFAT5 → KLF7 (>>) |
| NFAT5 → KRAS (>>) |
| NFAT5 → KREMEN2 (>>) |
| NFAT5 → LIMK1 (>>) |
| NFAT5 → LYAR (>>) |
| NFAT5 → MAP2K5 (>>) |
| NFAT5 → MAP3K3 (>>) |
| NFAT5 → MEF2A (>>) |
| NFAT5 → MVK (>>) |
| NFAT5 → NCOA3 (>>) |
| NFAT5 → NFKBIA (>>) |
| NFAT5 → NFKBIZ (>>) |
| NFAT5 → NRIP1 (>>) |
| NFAT5 → PPP1R12B (>>) |
| NFAT5 → PRKCI (>>) |
| NFAT5 → SERPINB2 (>>) |
| NFAT5 → SMAD5 (>>) |
| NFAT5 → SOS1 (>>) |
| NFAT5 → SOX3 (>>) |
| NFAT5 → SOX9 (>>) |
| NFAT5 → STAT5B (>>) |
| NFAT5 → SYK (>>) |
| NFAT5 → SYNJ2 (>>) |
| NFAT5 → TCF4 (>>) |
| NFAT5 → TMEM175 (>>) |
| NFAT5 → TNFAIP3 (>>) |
| NFAT5 → UBQLN2 (>>) |
| NFAT5 → WBP4 (>>) |
| NFAT5 → WNT5A (>>) |
| NFAT5 → YWHAB (>>) |
